Olga Ab

3PUBLICATIONS
38CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 16, 2026
Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science.

Rajeev Menon, Emarjola Bako, Shuhan Liu

|May 05, 2022
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.

Juniper A Scribner, Stuart W Hicks, Kerstin W Sinkevicius

|Nov 12, 2020
Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody-Drug Conjugates to Increase In Vivo Efficacy.

Jose F Ponte, Leanne Lanieri, Eshita Khera

Pageof 1

Frequent Collaborators

1 joint publications

Michael L Miller

1 joint publications

Juniper A Scribner

1 joint publications

Stuart W Hicks

1 joint publications

Kerstin W Sinkevicius

1 joint publications

Nicholas C Yoder

1 joint publications

Gundo Diedrich

1 joint publications

Jennifer G Brown

1 joint publications

Jacquelynn Lucas

1 joint publications

Megan E Fuller

1 joint publications

Thomas Son

Frequent Collaborators

1 joint publications

Michael L Miller

1 joint publications

Juniper A Scribner

1 joint publications

Stuart W Hicks

1 joint publications

Kerstin W Sinkevicius

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

10.1K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

7.7K
See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

10.1K
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

7.7K
See more related videos